Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (121-130 of 274) with videos related to

Pageof 28
Sort By:
International Journal of Dermatology|September 15, 2011
A case of erythrokeratodermia variabilis with connexin 31 gene mutation (Cx31F137L)Tiago Torres, Gloria Velho, Madalena Sanches, et al.
European Journal of Dermatology : EJD|April 24, 2010
Widespread comedones as the sole clinical manifestation of follicular mycosis fungoidesTiago Torres, Gloria Velho, Rosário Alves, et al.
Drugs in Context|September 15, 2025
Celebrating milestones and embracing innovation: the next chapter for Drugs in ContextSarah L Anderson, Arduino A Mangoni, Tiago Torres
The Journal of International Medical Research|November 19, 2024
IL-13 inhibition in the treatment of atopic dermatitis - new and emerging biologic agentsCarlos Teixeira, Orhan Yilmaz, Diana Bernardo, et al.
Acta Medica Portuguesa|November 7, 2013
[Psoriasis and cardiovascular disease]Tiago Torres, Rita Sales, Carlos Vasconcelos, et al.
Molecular Diagnosis & Therapy|October 1, 2013
Genetic markers for cardiovascular disease in psoriasis: the missing pieceTiago Torres, Andrea Chiricozzi, Sergio Chimenti, et al.
The Journal of Dermatological Treatment|June 13, 2022
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitorsCláudia Oliveira Maçães, Ana Maria Lé, Tiago Torres
Drug Development Research|October 21, 2015
Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and MalignancyRui Pereira, Paula Lago, Raquel Faria, et al.
Current Drug Safety|June 20, 2017
Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory DiseasesRui Pereira, Raquel Faria, Paula Lago, et al.
Frontiers in Medicine|February 1, 2021
A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease DomainsTiago Torres, Anabela Barcelos, Paulo Filipe, et al.
Pageof 28

Showing results (121-130 of 274) with videos related to

Sort By:
Pageof 28
International Journal of Dermatology|September 15, 2011
A case of erythrokeratodermia variabilis with connexin 31 gene mutation (Cx31F137L)Tiago Torres, Gloria Velho, Madalena Sanches, et al.
European Journal of Dermatology : EJD|April 24, 2010
Widespread comedones as the sole clinical manifestation of follicular mycosis fungoidesTiago Torres, Gloria Velho, Rosário Alves, et al.
Drugs in Context|September 15, 2025
Celebrating milestones and embracing innovation: the next chapter for Drugs in ContextSarah L Anderson, Arduino A Mangoni, Tiago Torres
The Journal of International Medical Research|November 19, 2024
IL-13 inhibition in the treatment of atopic dermatitis - new and emerging biologic agentsCarlos Teixeira, Orhan Yilmaz, Diana Bernardo, et al.
Acta Medica Portuguesa|November 7, 2013
[Psoriasis and cardiovascular disease]Tiago Torres, Rita Sales, Carlos Vasconcelos, et al.
Molecular Diagnosis & Therapy|October 1, 2013
Genetic markers for cardiovascular disease in psoriasis: the missing pieceTiago Torres, Andrea Chiricozzi, Sergio Chimenti, et al.
The Journal of Dermatological Treatment|June 13, 2022
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitorsCláudia Oliveira Maçães, Ana Maria Lé, Tiago Torres
Drug Development Research|October 21, 2015
Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and MalignancyRui Pereira, Paula Lago, Raquel Faria, et al.
Current Drug Safety|June 20, 2017
Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory DiseasesRui Pereira, Raquel Faria, Paula Lago, et al.
Frontiers in Medicine|February 1, 2021
A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease DomainsTiago Torres, Anabela Barcelos, Paulo Filipe, et al.
Pageof 28